Hyperglycaemia as Cardiovascular Risk in Type 2 Diabetes

  • P. Brunetti
  • G. Perriello


Cardiovascular disease is responsible for approximately 70% of all causes of death in type 2 diabetes (Laakso and Lehto 1997). Among cardiovascular diseases ischemic cardiopathy represents the primary cause of death, since mortality rates for coronary artery disease (CHD) are 2–4 times greater in diabetics than in non diabetic individuals (Haffner et al. 1998). Cerebrovascular events are the second cause of death in patients with type 2 diabetes.


Glycaemic Control Macrovascular Complication Multiple Risk Factor Intervention Trial Oral Hypoglycaemic Drug Diabetes Epidemiology 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Andersson DKG, Svardsudd K (1995) Long-term glycemic control relates to mortality in type II diabetes. Diabetes Care 18:1534–43.PubMedCrossRefGoogle Scholar
  2. Brownlee M (1994) Glycation and diabetic complications. Diabetes 43:836–41.PubMedGoogle Scholar
  3. Ceriello A (1997) Acute hyperglycaemia and oxidative stress generation. Diabet Med. 14 Suppl 3:S45–9.PubMedCrossRefGoogle Scholar
  4. Coutinho M, Gerstein HC, Wang Y, Yusuf S (1999) The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care 22:233–40 Will new diagnostic criteria for diabetes mellitus change phenotype of patients with diabetes? Reanalysis of European epidemiological data. DECODE Study Group on behalf of the European Diabetes Epidemiology Study Group (1998) BMJ 317:371–5.Google Scholar
  5. Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diag¬nostic criteria. The DECODE study group. European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative analysis Of Diagnostic criteria in Europe (1999) Lancet 354:617–21.Google Scholar
  6. Qiao Q, Tuomilehto J (2001) Diagnostic criteria of glucose intolerance and mortality. Minerva Med. 92:113–9.PubMedGoogle Scholar
  7. Gall MA, Borch-Johnsen K, Hougaard P, Nielsen FS, Parving HH (1995) Albuminuria and poor glycemic control predict mortality in NIDDM. Diabetes 44:1303–9.PubMedCrossRefGoogle Scholar
  8. Garcia MJ, McManara PM, Gordon T, Kannel WB (1983) Morbidity and mortality in diabetics in the Framingham population. Diabetes 23:336–341.Google Scholar
  9. Hanefeld M, Fischer S, Julius U, Schulze J, Schwanebeck U, Schmechel H, Ziegelasch HJ, Lindner J (1996) Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabe¬tes Intervention Study, 11-year follow-up. Diabetologia 39:1577–83.PubMedCrossRefGoogle Scholar
  10. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M (1998) Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 339:229–34.PubMedCrossRefGoogle Scholar
  11. Harris MI (1998) Diabetes in America: epidemiology and scope of the problem. Diabetes Care 21 Suppl 3:C11–4.PubMedGoogle Scholar
  12. Klein R (1995) Hyperglycemia and microvascular and macrovascular disease in diabetes. Diabetes Carei8:258–68.CrossRefGoogle Scholar
  13. Kuusisto J, Mykkanen L, Pyorala K, Laakso M (1994) NIDDM and its metabolic control predict coronary heart disease in elderly subjects. Diabetes 43:960–7.PubMedCrossRefGoogle Scholar
  14. Kuusisto J, Mykkanen L, Pyorala K, Laakso M (1994) Non-insulin-dependent diabetes and its metabolic control are important predictors of stroke in elderly subjects. Stroke 25:1157–64 International Collaborative Group (1979) Asymptomatic hyperglycemia and coronary artery disease: a series of papers by the International Collaborative Group based on studies in fifteen populations. J Chronic Dis 32:829–837.CrossRefGoogle Scholar
  15. Laakso M and Lehto S (1997) Epidemiology of macrovascular disease in diabetes. Diabetes Rev 5:294–315.Google Scholar
  16. Lehto S, Ronnemaa T, Pyorala K, Laakso M (1996) Predictors of stroke in middle-aged patients with non-insulin-dependent diabetes. Stroke 27:63–8.Google Scholar
  17. Lehto S, Ronnemaa T, Haffner SM, Pyorala K, Kallio V, Laakso M (1997) Dyslipidemia and hyperglycemia predict coronary heart disease events in middle-aged patients with NIDDM. Diabetes 46:1354–9.Google Scholar
  18. Pyorala K, Laakso M, Uusitupa M (1987) Diabetes and atheroslerosis: an epidemiologic view. Diabetes Metab Rev 3:463–524.PubMedCrossRefGoogle Scholar
  19. Stamler J, Vaccaro O, Neaton JD, Wentworth D (1993) Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 16:434–44.PubMedCrossRefGoogle Scholar
  20. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group (1998). Lancet 352:837–53.Google Scholar
  21. Uusitupa MI, Niskanen LK, Siitonen O, Voutilainen E, Pyorala K Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type 2 (non- insulin-dependent) diabetic and non-diabetic subjects. Diabetologia 36:1175–84.Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2003

Authors and Affiliations

  • P. Brunetti
  • G. Perriello

There are no affiliations available

Personalised recommendations